SEC Form D filing

Triana Biomedicines, Inc., 2025-12-04

An SEC Form D private-offering notice from Lexington, MA, a $120,061,960 filer-stated offering target in Biotech. Filed 2025-12-04. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Triana Biomedicines, Inc. site↗ Verified via SEC Form D

Biotechnology company developing molecular glue degrader therapeutics targeting cancer, including an ALK-targeted lead program.

Filed 2025-12-04Filed to raise $120,061,960First money in 2025-11-26Raised so far $120,061,960HQ (as filed) Lexington, MASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified trianabio.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source